Primary Care Rebate Schemes (PCRS)
Total Page:16
File Type:pdf, Size:1020Kb
Primary Care Rebate Schemes (PCRS) As of July 2021, Barking & Dagenham, Havering and Redbridge Integrated Care Partnership, North East London CCG , has signed up to the following primary care rebates (Company name – product(s) - (agreement start/expiry dates)): Medicines • AstraZeneca - Zoladex (Gosarelin) (1st October 2015 – 31st December 2019) thereafter rebate shall continue until agreement terminated by either party) • Chiesi Ltd – Clenil (betamethasone diproprionate) (1st July 2019 – 30th June 2021) • Daiichi Sankyo UK Ltd - Edoxaban (1st November 2018 – 31st December 2024) • Ferring Pharmaceuticals Ltd – Firmagon (Degarelix) (1st January 2017 – 31st December 2021) • Fontus Health Ltd - Luventa XL (Galantamine) (1st April 2016 – until agreement terminated by either party) • Fontus Health Ltd - Zaluron XL (Quetiapine) (1st April 2016 – until agreement terminated by either party) • Kyowa Kirin Ltd - Adcal D3 (Calcium Carbonate/Colecalciferol) (1st October 2015 – until agreement terminated by either party) • Merck Serono - Glucophage SR (Metformin SR) (1st January 2013 – 31st March 2023) • Sandoz - AirFluSal Forspiro (Fluticasone/Salmeterol) (1st August 2018 – 31st March 2022) • Sandoz - AirFluSal MDI (Fluticasone/Salmeterol) (1st August 2018 – 31st March 2022) • Takeda - Prostap (Leuprorelin) (1st April 2018 – 31st March 2020 thereafter rebate shall continue for 12 monthly rollover until agreement terminated by either party) Food supplements • Fontus Health Ltd - Fontus Health Range of Food Supplements (1st July 2014 –30th June 2021) Page: 1 Primary Care Rebate Schemes (PCRS) Terminated agreements • Agamatrix - WaveSense Jazz (1st January 2014 – 31st January 2018) • Aymes - Aymes Crème/2kcal/Shake starter (1st January 2020 – 31st December 2020) • AstraZeneca - Oxis (1st January 2016 – 31st December 2018) • AstraZeneca - Symbicort (1st January 2016 – 31st December 2017) • Neon Diagnostics - GlucoLab (1st January 2014 – 31st December 2016) • Sanofi - Apidra, Insuman and Lantus (Insulin portfolio) (1st April 2014 – 31st March 2017) • Sanofi - Clexane (1st July 2015 – 31st March 2018) • GlucoRx - Lancets (1st January 2014 – 30th April 2019) • GlucoRx - Nexus (1st January 2014 – 30th April 2019) • GlucoRx - Pen Needles (1st August 2014 – 30th April 2019) • Aymes - Aymes Complete (1st January 2019 – 31st December 2019) • Bayer - Contour Next (1st April 2014 – 31st October 2019) • GSK - Seretide (Fluticasone/Salmeterol) (1st June 2015 – 31st March 2020) • MSD - Januvia (sitagliptin) – (1st September 2017- 31st July 2020) • Intrapharm Laboratories Ltd - Aquamax (1st December 2018 – 30th November 2020) • Intrapharm Laboratories Ltd - Carbocisteine (1st December 2018 – 30th November 2020) • Kyowa Kirin Ltd - Stexerol D3 (Colecalciferol) (1st April 2019 – 31st July 2021) Page: 2 .